Esther van den Boom, CPA

Chief Financial Officer

Esther van den Boom, CPA (Chief Financial Officer) brings over 19 years of accounting and finance experience to Artiva. Esther is the founder of van den Boom & Associates, a finance and accounting firm that specializes in supporting life science companies. At van den Boom, Esther has supported several private and public companies as Chief Financial Officer including through various financings including preferred stock, venture debt, initial public offerings and secondary offerings. Most recently, Esther was head of finance for Equillium Biosciences and Phathom Pharmaceuticals from inception through their initial public offerings. Prior to founding van den Boom, Esther was a Senior Manager at Ernst & Young where she worked closely with many early-stage, venture backed companies including working with several from inception through their successful transition to a public company. At Ernst & Young, Esther regularly oversaw SEC filings and registration statements, complex accounting and auditing matters such as revenue recognition, product launches, debt and equity transactions, complex valuations and SOX 404 implementations. Throughout her career, Esther has worked closely with over 50 life science companies at all stages. Esther received a B.A. in Economics from the University of California, San Diego and a M.S. in Accountancy from San Diego State University and is a licensed CPA.

Sign up for news updates

  • Twitter
  • LinkedIn

Privacy Policy  |  Terms
© Artiva Biotherapeutics, Inc., 2020